Specifically, FLRT2 was downregulated while MAD1L1, PHLDA2, PLAT, CC2D1B, CDKN2A and RUNX3 were upregulated in both melanoma and in Group 2 and Group 3 SFs. Here, RUNX3 is linked to melanoma.